Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 2Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 277Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Pain, Postoperative 43Head and Neck Neoplasms 43Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

Imiquimod 1BF-200 ALA 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Hutchinson's Melanotic Freckle × Clear all
NCT02685592 2018-05-30

LM PDT

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
10 enrolled

Hutchinson's Melanotic Freckle

NCT01161888 2012-06-20

LIMIT-1

University Hospital Birmingham NHS Foundation Trust

Phase 4 Completed
30 enrolled

Hutchinson's Melanotic Freckle

Data powered by HemOnc (CC BY 4.0) Colophon âš¡